111 related articles for article (PubMed ID: 10707823)
21. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
22. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
Kameyama H; Takeda K; Kusaba T; Narumiya H; Tanda S; Kuwahara N; Yamada K; Tamagaki K; Okigaki M; Hatta T; Sasaki S
Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
25. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
Benova M; Herichova I; Stebelova K; Paulis L; Krajcirovicova K; Simko F; Zeman M
Hypertens Res; 2009 Apr; 32(4):242-7. PubMed ID: 19262491
[TBL] [Abstract][Full Text] [Related]
26. Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension.
Vrbjar N; Bernátová I; Pechánová O
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():10-2. PubMed ID: 10707824
[TBL] [Abstract][Full Text] [Related]
27. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
[TBL] [Abstract][Full Text] [Related]
28. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.
Zicha J; Pechánová O; Dobesová Z; Kunes J
Clin Sci (Lond); 2003 Oct; 105(4):483-9. PubMed ID: 12816535
[TBL] [Abstract][Full Text] [Related]
29. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
Pechánová O; Bernátová I; Pelouch V; Simko F
J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
[TBL] [Abstract][Full Text] [Related]
30. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of prior physical conditioning on relaxing response of corpus cavernosum from rats made hypertensive by nitric oxide inhibition.
Claudino MA; Priviero FB; Camargo EA; Teixeira CE; De Nucci G; Antunes E; Zanesco A
Int J Impot Res; 2007; 19(2):189-95. PubMed ID: 16915305
[TBL] [Abstract][Full Text] [Related]
32. Effect of exercise on blood pressure in rats with chronic NOS inhibition.
Kuru O; Sentürk UK; Demir N; Yeşilkaya A; Ergüler G; Erkiliç M
Eur J Appl Physiol; 2002 Jun; 87(2):134-40. PubMed ID: 12070623
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide synthases are involved in the modulation of cardiovascular adaptation in hemorrhaged rats.
Balaszczuk AM; Arreche ND; Mc Laughlin M; Arranz C; Fellet AL
Vascul Pharmacol; 2006 Jun; 44(6):417-26. PubMed ID: 16697268
[TBL] [Abstract][Full Text] [Related]
34. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
36. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
37. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
38. Postischemic recovery and oxidative stress are independent of nitric-oxide synthases modulation in isolated rat heart.
Vergely C; Perrin-Sarrado C; Clermont G; Rochette L
J Pharmacol Exp Ther; 2002 Oct; 303(1):149-57. PubMed ID: 12235245
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
[TBL] [Abstract][Full Text] [Related]
40. L-NAME-induced protein remodeling and fibrosis in the rat heart.
Pechánová O; Bernátová I; Pelouch V; Babál P
Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
